John TaylorGlobal Head of Business Development at RibocureSpeaker
Agenda Sessions
Presentation: Advancing siRNA Therapeutics for Cardiovascular and Renal Diseases - Progress and Future Directions
, 15:00View SessionClosing Remarks & End of Congress
, 17:20View Session
